• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Teva Pharmaceutical

A puzzle of the brain with one missing piece
Pharma

Teva bags long-sought reformulated olanzapine schizophrenia nod

With a Friday go-ahead from the FDA, another key piece of Teva’s innovation revamp strategy has fallen into place.
Fraiser Kansteiner Oct 9, 2026 9:56am
deal handshake business cooperation partnerships

Teva, Samsung Bioepis deepen biosimilar bonds with new deal

Oct 2, 2026 10:00am
drug prices biologics drug costs IRA money cash payment co-pay

White House unveils next round of MFN drug pricing deals

Aug 31, 2026 5:10pm
Teva
Favicon Fierce Biotech

Teva saddles up as bidder for bankrupt BioXcel’s CNS assets

Aug 28, 2026 9:17am
Turkey flag Turkey magnifying glass Turkey investigation

Teva's patent and communications strategies in Turkey face probe

Aug 26, 2026 8:15am
Aurinia

Aurinia deal with Teva keeps Lupkynis generic in check until '36

Aug 20, 2026 11:28am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings